Ownership
Private
Employees
~10000
Stage
Commercial
Modalities
Small molecule

Kremers Urban Pharmaceuticals General Information

Specialty generic pharmaceutical company focused on high barrier to entry drugs including extended release formulas, unusual dosage forms like patches, liquids and injectables, and scheduled substances.

Contact Information

Website
Primary Industry
Pharma
Corporate Office
Princeton, New Jersey
United States

Drug Pipeline

No pipeline data available

For full access to Kremers Urban Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

UCB, Lannett

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Kremers Urban Pharmaceuticals Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Kremers Urban Pharmaceuticals's complete valuation and funding history, request access »

Kremers Urban Pharmaceuticals Investors

Prior owners included Advent International & Avista Capital Partners before sale to Lannett Co.; previously owned by UCB S.A., Schwarz Pharma AG.
Investor Type: Venture Capital
Holding: Minority